Nuvo Pharmaceuticals Inc
TSX:MRV

Watchlist Manager
Nuvo Pharmaceuticals Inc Logo
Nuvo Pharmaceuticals Inc
TSX:MRV
Watchlist
Price: 1.35 CAD Market Closed
Market Cap: 15.4m CAD

Wall Street
Price Targets

MRV Price Targets Summary
Nuvo Pharmaceuticals Inc

There are no price targets for MRV.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Nuvo Pharmaceuticals Inc Competitors:
Price Targets
002422
Sichuan Kelun Pharmaceutical Co Ltd
28% Upside
4519
Chugai Pharmaceutical Co Ltd
8% Upside
1760
Panion & BF Biotech Inc
31% Upside
TBPH
Theravance Biopharma Inc
45% Upside
SECARE
Swedencare AB (publ)
34% Upside
CAPLIPOINT
Caplin Point Laboratories Ltd
30% Upside
LINCOLN
Lincoln Pharmaceuticals Ltd
113% Upside
CRON
Cronos Group Inc
26% Upside

Revenue
Forecast

Revenue Estimate
Nuvo Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for Nuvo Pharmaceuticals Inc's revenue is 18%. The projected CAGR for the next 2 years is 5%.

18%
Past Growth
5%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Nuvo Pharmaceuticals Inc

The compound annual growth rate of Nuvo Pharmaceuticals Inc's operating income for the next 4 years is -26%.

N/A
Past Growth
-26%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Nuvo Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-28%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MRV's stock price target?
Not Available

MRV doesn't have any price targets made by Wall Street professionals.

What is Nuvo Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
5%

For the last 8 years the compound annual growth rate for Nuvo Pharmaceuticals Inc's revenue is 18%. The projected CAGR for the next 2 years is 5%.

What is Nuvo Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
-26%

The compound annual growth rate of Nuvo Pharmaceuticals Inc's operating income for the next 4 years is -26%.

Back to Top